Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia

INTRODUCTION: Central neuropathic pain (CNeP) is difficult to treat and has diverse etiology, including spinal cord injury (CNePSCI), Parkinson’s disease (CNePPD), and central post-stroke pain (CPSP). The safety and efficacy of mirogabalin have been demonstrated in short-term trials, including patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ushida, Takahiro, Katayama, Yoichi, Hiasa, Yoichi, Nishihara, Makoto, Tajima, Fumihiro, Katoh, Shinsuke, Tanaka, Hirotaka, Maeda, Takeshi, Furusawa, Kazunari, Kakehi, Yoshihiro, Kikumori, Kunika, Kuroha, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290008/
https://www.ncbi.nlm.nih.gov/pubmed/37115464
http://dx.doi.org/10.1007/s40122-023-00513-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290008/
https://www.ncbi.nlm.nih.gov/pubmed/37115464
http://dx.doi.org/10.1007/s40122-023-00513-1

Ejemplares similares